Q&A With Jagmeet Singh From Harvard Medical School: Looking at New Developments in Atrial Fibrillation Treatment

Atrial fibrillation is a common condition cardiologists face on a regular basis. How best to treat those patients is an area still being worked on in the field and in practices around the world.

Jagmeet Singh, MD, PhD, from Harvard Medical School discussed some of the newer treatment options during the recent annual conference of the European Society of Cardiology. Singh, who also serves as Deputy Editor for JACC: Clinical Eletrophysiology said there are new devices, medications, and procedures that can help make the condition more managable for patients and doctors alike.